Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Isfahan Healthy Heart Programme: A Comprehensive Integrated Community-Based Programme for Cardiovascular Disease Prevention and Control. Design, Methods and Initial Experience Publisher Pubmed



Sarrafzadegan N1, 2 ; Sadri G1 ; Malek Afzali H1 ; Baghaei M1 ; Mohammadi Fard N1 ; Shahrokhi S1 ; Tolooie H1 ; Poormoghaddas M1 ; Sadeghi M1 ; Tavassoli A1 ; Rafiei M1 ; Kelishadi R1 ; Rabiei K1 ; Bashardoost N1 Show All Authors
Authors
  1. Sarrafzadegan N1, 2
  2. Sadri G1
  3. Malek Afzali H1
  4. Baghaei M1
  5. Mohammadi Fard N1
  6. Shahrokhi S1
  7. Tolooie H1
  8. Poormoghaddas M1
  9. Sadeghi M1
  10. Tavassoli A1
  11. Rafiei M1
  12. Kelishadi R1
  13. Rabiei K1
  14. Bashardoost N1
  15. Boshtam M1
  16. Asgary S1
  17. Naderi G1
  18. Changiz T1
  19. Yousefie A1
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Cardiovascular Center, WHO Collab. Ctr. for Res./Train., Isfahan Univ. of Medical Sciences, Isfahan, Iran
  2. 2. Dept. Isfahan Cardiovasc. Res. Ctr., Isfahan Univ. of Medical Science, Isfahan, PO Box 81465-1148, Iran

Source: Acta Cardiologica Published:2003


Abstract

The Isfahan Healthy Heart Programme (IHHP) is a five to six year comprehensive integrated community-based programme for cardiovascular diseases (CVD) prevention and control via reducing CVD risk factors and improvement of cardiovascular healthy behaviour in a target population. IHHP started late in 1999 and will be finished in 2005-2006. A primary survey was done to collect baseline data from interventional (Isfahan and Najaf-Abad) and reference (Arak) communities. In a two-stage sampling method, we randomly selected 5 to 10 percent of households from randomly selected clusters. Then individuals aged ≥ 19 years were selected for the survey. This way, data from 12,600 individuals (6300 in interventional counties and 6300 in the reference county) was collected and stratified according to living area (urban vs. rural) and different age and sex groups. The samples underwent a 30-minute interview to complete validated questionnaires containing questions on demography, socioeconomic status, smoking behaviour, physical activity, nutritional habits and other behaviour regarding CVD. Blood pressure and body mass index (BMI) measurements were done and fasting blood samples were taken for two hours post load plasma glucose (2 hpp), serum (total, HDL and LDL) cholesterol and triglyceride levels. A twelve-lead electrocardiogram was recorded in all persons above 35 years of age. Community-wide surveillance of deaths, hospital discharges, myocardial infarction and stroke registry was carried out in the intervention and control areas. Four to five years of interventions based on different categories such as mass media, community partnerships, health system involvement and policy and legislation have started in the intervention area while Arak will be followed without intervention. Considering the results of the baseline surveys. (assessments needed, the objectives, existing resources and the possibility of national implementation) the interventions were planned. They were set based on specific target groups like school children, women, work-site, health personnel, high-risk persons, and community leaders were actively engaged as decision makers. A series of teams was arranged for planning and implementation of the intervention strategies. Monitoring will be done on small samples to assess the effect of different interventions in the intervention area. While four periodic surveys will be conducted on independent samples to assess health behaviours related to CVD risk factors in the intervention and reference areas, the original pre-intervention subjects aged more than 35 years will be followed in both areas to assess the individual effect of interventions and outcomes like sudden death, fatal and nonfatal MI and stroke. The whole baseline survey will be repeated on the original and an independent sample in both communities at the end of the study.
Other Related Docs
11. The Modifiable Noncommunicable Risk Factors Among an Iranian Population, Southeast Asian Journal of Tropical Medicine and Public Health (2012)
21. The Isfahan Cohort Study: Rationale, Methods and Main Findings, Journal of Human Hypertension (2011)
33. Factor Analysis of Metabolic Syndrome Among Iranian Male Smokers, Iranian Journal of Medical Sciences (2005)
34. White Rice Consumption and Cvd Risk Factors Among Iranian Population, Journal of Health, Population and Nutrition (2013)
39. Factors Associated With Cigarette Smoking in Central Parts of Iran, Asian Pacific Journal of Cancer Prevention (2017)
47. Health-Promoting Lifestyle Among People Without Heart Disease in Isfahan, International Journal of Preventive Medicine (2018)